Sales up 6.7% like-for-like
Operating income before non-recurring items up 5%
Net income up 7.7% (excluding capital gains on divestments in 2006 and 2007)
MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News:
bioMérieux (Paris:BIM), a global leader in the field of in vitro diagnostics, today announced its results for the six months ended June 30, 2007.
